Wednesday, August 12, 2015 7:07:53 AM
He also has put DF and Dr Emil Frei in line for failed cancer treatment and somehow connected 4000 to 9000 deaths to this trial based treatment and costing $3 B.
This is a risky path for the author -CTIX is microcap whose credibility is already shaky based on lot of articles- but DF is a big fish in Cancer area and the author is challenging their credibility.
Someone should notify them about this article so let their PR machine decide how to handle this attack on their credibility (not sure if they will engage the author in any rebuttals but the written words are toxic)
From the blog - Quote"
Bulls Point to Dana Farber, Which has Made Mistakes Before: 4,000-9,000 Died, $3 Billion Wasted
CTIX bulls have repeatedly pointed to the involvement of Dana Farber as validating the potential of Cellceutix's drug Kevetrin. Dana Farber is clearly a respected cancer institute, no doubt about that. But it is far from perfect. In fact, starting in the early 1980s, Dana Farber was the epicenter of a failed cancer treatment that according to respected scientific publication Discover Magazine, ultimately ended up killing between 4,000 and 9,000 women, "not from the cancer, but from the treatment." This fiasco ended up costing an estimated $3 billion and impacting an estimated 30,000 patients.
To be clear, not all of these patients were treated at Dana Farber (the treatment was conceived at Dana Farber and then spread from there). And the article cited in Discover has nothing directly to do with Kevetrin, Cellceutix, or Cellceutix's current management team. It does, however, pull the rug directly out from under the legion of shareholders who own CTIX stock based on the premise that Dana Farber is infallible. This is simply not true.
The story should be read in detail. It's a sad tale of poor science combined with enriching financial incentives (sounds familiar) that led to lethal cancer treatments. Perhaps most shockingly of all, the treatment was the "brainchild" of Emil Frei, who at the time was a director at Dana-Farber. In fact at one point, Emil Frei is said to have claimed, "We've got a cure for cancer."
By all appearances, this is the same Emil Frei that CTIX has touted as being the founder of CTIX, a supposed "legend in the field of oncology" according to a recent CTIX press release. If only the 4,000 - 9,000 needless deaths at the cost of $3 billion were only a legend instead of a reality.
Is Kevetrin the next bomb to come out of Dana Farber? Time will tell. Personally, I don't think Kevetrin will even get off the ground, so it's probably moot.
If Krishna Menon commits administrative errors about where he went to school, how good could his cancer science be?
If Dana Farber has succumbed to bad cancer science because of financial motives before, who's to say it couldn't happen again?
UnQuote
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM